Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PSTV

PSTV News

Newswire

07:36

Plus Therapeutics Presents Promising Clinical Data for REYOBIQ in CNS Cancers.

13:31

Plus Therapeutics: Boral Capital maintains Buy, PT raised to $5 from $5

07:37

Plus Therapeutics Presents Rhenium Nanoliposome for Leptomeningeal Metastases Treatment.

06:02

Ascendiant Capital Maintains Buy Rating on Plus Therapeutics, PT Down to $19

04:46

Plus Therapeutics shares surge 10.30% premarket after CNSide subsidiary secures Humana coverage for 67 million patients with CNSide CSF assay.

View More

About PSTV

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More